Cure Today3d
Understanding the FDA Approval of Enhertu in HER2-Low and -Ultralow Breast Cancer
Dr. Debu Tripathy breaks down the FDA approval of Enhertu in unresectable or metastatic HR-positive, HER2-low or -ultralow ...
Cure Today10d
An Expert Explains the Enhertu Approval in HER2-Low and -Ultralow Breast Cancer
Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or ...
Mining Weekly5d
New ultra-low iridium collaboration is promising major green hydrogen magnification
The acronyms are becoming more intense, with PTE, which stands for porous transport electrodes, the latest one, amid the ...